Back to BALYASNY ASSET MANAGEMENT L.P. BALYASNY ASSET MANAGEMENT L.P.

CYPHCYPH
4 quarters

Position history for BALYASNY ASSET MANAGEMENT L.P.BALYASNY ASSET MANAGEMENT L.P.'s holdings in LEAP THERAPEUTICS INC

No. Balyasny Asset Management exited its CYPH (Leap Therapeutics) position in Q4 2024. Its Q3 2024 13F listed 3,085,104 shares worth $7.9M. Balyasny Asset Management first reported CYPH in Q1 2024 and held it in 3 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$1.8M

Total Shares Change

-670,543

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q4
Latest
Exited
0
-100.0%
$00.0%$2.88
0
2024-Q3
Decreased
3.1M
-0.5%
$7.9M0.0%$2.57
0
2024-Q2
Increased
3.1M
+362.3%
$6.1M0.0%$1.96
44
2024-Q1
New
670,543
-
$1.8M0.0%$2.66
36

Other major holders of CYPH: BAKER BROS. ADVISORS LP, Point72 Asset Management, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used